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Objective: Shorter leukocyte telomere length (LTL) is associated with higher incidence of coronary heart
disease (CHD) and increased mortality. We examined the association of LTL with coronary artery calci-
ﬁcation (CAC), which reﬂects the cumulative burden of coronary atherosclerosis, in an urban Arab sample
of Palestinians, a population at high risk of CHD.
Methods: Using a cross-sectional design, a random sample of East Jerusalem residents, comprising 250
men aged 45e77 and women aged 55e76 and free of CHD or past stroke, was drawn from the Israel
national population register. LTL was measured by Southern blots. CAC was determined by 16-slice
multidetector helical CT scanning using Agatston scoring. We applied multivariable logistic modeling
to examine the association between sex-speciﬁc tertiles of LTL and CAC (comparing scores >100 vs.<100,
and the upper third vs. the lower 2 thirds), controlling for age, sex, education and coronary risk factors.
Results: CAC, evident in 65% of men and 52% of women, was strongly associated with age (sex-adjusted
Spearman’s rho 0.495). The multivariable-adjusted odds ratios for CAC >100 (found in 30% of men and
29% of women) were 2.92 (95% CI 1.28e6.68) and 2.29 (0.99e5.30) for the lower and mid-tertiles of LTL
vs. the upper tertile, respectively (Ptrend ¼ 0.008). Findings were similar for CAC scores in the upper tertile
(Ptrend ¼ 0.006), and persisted after the exclusion of patients with diabetes or receiving statins.
Conclusions: Shorter LTL was associated with a greater prevalence of asymptomatic coronary athero-
sclerosis in an urban Arab population-based sample. Mechanisms underlying this association should be
sought.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license.and Community Medicine,
rem, Jerusalem 91120, Israel.
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Shorter leukocyte telomere length (LTL) has been shown to be
associated with a higher incidence of coronary heart disease (CHD)
(e.g. [1,2]) and with increased mortality [3,4]. With regard to the
association of LTL with underlying atherosclerosis, LTL has been
inconsistently related to carotid intima-media thickness (C-IMT)
[2,5,6]. Coronary artery calciﬁcation (CAC), in contrast with C-IMT,
predicts CHD independently of the traditional risk factors (e.g. [7,8]),
and was the strongest predictor of CHD risk among a series of
“newer” CHD risk markers evaluated in the prospective Rotterdam
study of people initially free of manifest CHD. In contrast, C-IMT did
notplayan independent role [9]. CAC is indicative of theextentof the license.
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clinical measure of coronary artery disease. Of two studies in young
to middle-aged adults that examined the association of LTL with
CAC, one showed a strong cross-sectional association of LTLwith the
presence and extent of CAC inmenandwomenaged40e64 [11]. The
second reported, in a small sample of 129 men aged 33e45, that
shorter LTL predicted greater CAC progression in the presence of
high leukocyte telomerase activity, but the reversewhen telomerase
activity was low, with no protective association evident for long LTL
[12]. These ﬁndings appear to conﬂict with those of Mainous et al.
[11]. The mechanisms underlying a LTL-atherosclerosis association
are unknown, and it is debated whether the association is causal.
Competing hypotheses have attempted to mechanistically link LTL
with atherosclerosis. A noncausal hypothesis posits that the rate of
LTL attrition in adulthood is an index of progression of atheroscle-
rosis, because both the pace of atherosclerosis and the rate of LTL
attrition are increased bychronic inﬂammation and oxidative stress.
If so, LTL dynamics according to the conventional view serve as a
record of the vascular injury that marks atherosclerosis. A
competinghypothesis proposes that telomere length endowment at
birth and its attrition during childhood are themaindeterminants of
LTL, which reﬂects the hematopoietic stem cell telomere reserves
and their ability to engage in vascular repair. In this context, LTL
attrition in adulthood might also play a contributory role in driving
TL below a critical level [13,14].
Palestinians have undergone a rapid epidemiologic transition
over the past century, and particularly so in the last 50 years, with
heart disease, cerebrovascular disease and cancer now the three
leading causes of death [15]. CHD incidence in East Jerusalem Pal-
estinians ranked particularly high in standardized international
comparisons with the World Health Organization MONICA pro-
gram [16]. CHD incidence and mortality in East Jerusalem Pales-
tinians were also high compared with the Jewish residents of
Jerusalem [16,17]. Although the underlying determinants of these
ﬁndings are unknown, the high prevalence of the metabolic syn-
drome and diabetes in Palestinians [15,18] may play a role.
It is within this context that we examined the cross-sectional
association of LTL with CAC in a population-based sample
randomly drawn from middle-aged and elderly Palestinian resi-
dents of East Jerusalem.
2. Methods
2.1. Study design
We undertook a cross-sectional, comparative population-based
investigation of Palestinian and Israeli residents of Jerusalem. The
study’s main goal was to identify differences between these two
populations that might explain the high risk of CHD evident in stan-
dardized international comparisons among the Palestinians. The
sampling methods of the Jerusalem Palestinian-Israeli Risk Factor
Studyhavebeenreported[19].Herewe focusonthePalestinianarmof
the study, as LTLdeterminationswere notmade for the Israeli sample.
In brief, following the Six-DayWar in 1967 Arab residents of East
Jerusalemwere accorded the legal status of permanent residents of
Israel, with access to the job market, social security and health
insurance, and are recorded in the Israel national population reg-
istry. An age-sex-stratiﬁed random sample of 2000 Palestinian
residents from East Jerusalem aged 25e74 (comprising 200 men
and 200 women in each 10-year age band, 25e34, 35e44.) was
drawn from the population registry. Participants were recruited
between 2005 and 2008 by a letter of invitation and follow-up
phone calls. Ineligibility criteria included inability to provide
informed consent, being institutionalized, housebound, pregnant
or within 3 months of giving birth, and having a serious healthdisorder (such as metastatic cancer or end-stage renal disease). Of
the Palestinian sample 29.5% could not be located, and of those
located 89.6% were eligible. The 970 participants represented a
response rate from all located eligible residents of 76.7%.
The examination comprised a face-to-face interview in Arabic
and clinical measurements using standardized methods. Blood
samples were collected after a 12-h fast, and CACwasmeasured at a
separate session usually within several weeks.
Eligible for the CT imaging were Palestinianmen aged45 years
and women aged 55 years who had participated in the initial
examination, were free of clinical manifestations of CHD and had a
BMI of <38 kg/m2 for women and <45 kg/m2 for men (thus
excluding 29 women and one man who exceeded these BMI limits
as they would have required a higher radiation dose in the CT
procedure than acceptable for healthy volunteers). By December 31,
2007 when we ceased CT examination for logistic reasons, 259 of
the 362 eligible Palestinians had been scanned (72%), 14% had
refused and 14% were being processed. A CT reading was not
available for 1 subject and 8 had missing measures of LTL, leaving
250 individuals for analysis.
All participants provided signed informed consent. The study
was authorized by the St Joseph Hospital, the Hadassah-Hebrew
University Medical Center, and the Israel Ministry of Health Ethics
(Helsinki) Committees. Participants were referred to their physi-
cians with their CAC results and interpretation.
2.2. CT imaging for coronary calciﬁcation
2.2.1. Image acquisition
The CT imaging and interpretation were done in 2005e2007 by
the Hadassah Imaging (Radiology) Department on the Ein Kerem
campus. Images were obtained with a 16-slice Philips BrillianceMX
8000 IDT multidetector helical CT scanner. The heart was scanned
from the base of the heart to the apex at 3 mm collimation with
rotation time of 0.5 s during a single breath-hold. No contrast
material was used. The ﬁeld-of-view was 25 cm. Images were ac-
quired in a low-dose setting [20] adjusted according to BMI levels
(Shemesh J, personal communication 2012, and Shemesh J, Evron R,
Konen E et al. Measurement of coronary calcium by adapting mAs
to body mass index: Prospective validation and reproducibility.
Abstract SSA03-06. Radiological Society of North America 90th
Scientiﬁc assembly, Nov 2004, Chicago, IL) so that exposures for
men ranged from 55 mAs (for BMI < 34 kg/m2) to 88 mAs
(for BMI > 42 kg/m2) and for women between 55 mAs (for
BMI < 28 kg/m2) to 98 mAs (for BMI > 35 kg/m2). Total scan
acquisition time was 20e30 s, depending on patient size. Axial
prospective ECG gating was used at 75% of the ReR interval.
2.2.2. Reading and scoring
The cardiac CT series was transferred to a Philips MXVIEW
workstation and evaluated using Heart-Beat CS software (Philips,
Haifa). The operator, a qualiﬁed radiologist, manually placed Re-
gions of Interest (ROIs) around selected areas within a sequence of
images. Philips CAC scoring software computed the calciﬁcation
scores by performing automatic calculation on CT numbers inside
these ROIs. The calciﬁcation quantiﬁcation included extracting in-
tensity histograms for each selected region, computing scores per
region and combining region scores into composite scores using
slice-thickness weighting. Agatston calciﬁcation scores were
calculated using a threshold of 130 Hounsﬁeld Units.
2.3. Leukocyte telomere length measurement
Buffy coat samples had been stored at80 C for 4e6 years prior
to shipment to Aviv’s laboratory in Newark, New Jersey. DNA was
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by Southern blot analysis of the terminal restriction fragment (TRF)
length as previously described [21]. The interassay coefﬁcient of
variation (CV), 1.9%, was computed from duplicate samples (both
drawn from the same extracted sample of DNA) of 930 Palestinian
examinees that included the 250 individuals of the current study.
The duplicates were measured on separate gels run on different
occasions. The mean LTL of the duplicates was used in the data
analysis. The CV in this study is similar to that determined by the
samemethod by the same laboratory in an impartial comparison of
LTL measurement by Southern blot vs. qPCR [22]. LTL measured by
Southern blot shows a very high degree of consistency over time
with correlations of 0.91e0.96 over follow-up periods of up to 13
years [23].
2.4. Covariates
Age was reported at interview and was also extracted from the
national population register. Education, smoking (which we
deﬁned as regularly smoking at least 1 cig/d or as pack-years) and
medication use were self-reported. BMI was calculated from
measured weight and height. Total energy expenditure due to
physical activity and leisure-time exercise alone were computed in
metabolic equivalents (METs) [19]. Diabetes was deﬁned as a fast-
ing glucose >125 mg/dl, and/or as 2 h post 75 g glucose challenge
>199 mg/dl, and/or oral or insulin treatment. Blood pressure was
taken as the average of 3 measures in seated position after a 5 min
rest using an automatic device. Fasting plasma lipids and lipopro-
teins were determined on fresh samples by enzymatic methods;
LDL-cholesterol was computed by the Friedewald method.
2.5. Statistical methods
Age is a dominant confounder being closely associated with
CAC and inversely related to LTL. Sex too is associated with LTL and
CAC. Consequently, all analyses were adjusted for age and sex. We
initially treated LTL, which was approximately normally distrib-
uted, as the dependent variable in linear regression models. Here
we grouped CAC scores into 3 groupsezero or no CAC, and below
or above the median of a positive CAC score. The main analysis
used multivariable logistic regression models with CAC as the
dependent variable and LTL grouped in sex-speciﬁc tertiles. We
categorized CAC in 2 prespeciﬁed modes: above/below a cutoff
score of 100 (as used for example in Refs. [7,24]) and the upper
tertile vs. the lower 2 tertiles of Agatston scores. Secondarily, we
assessed any vs. no CAC as reported by Mainous et al. [11],
although at older ages presence of CAC may be ubiquitous and
therefore not informative [10]. At the ﬁrst step we adjusted for sex
and age (model 1). We next adjusted for lifestyle variables
(smoking, BMI, leisure-time physical activity) and education
(model 2). We then introduced additional cardiovascular risk fac-
tors, of which only plasma triglycerides and the use of lipid-
lowering medications showed age-sex adjusted associations with
CAC. Nevertheless, we added a full set of risk factors (diabetes, LDL-
cholesterol, HDL-cholesterol, triglycerides, lipid lowering medica-
tions, and systolic blood pressure) (model 3). Last, we reduced the
model by allowing variables to be serially ejected in backward
elimination procedure with a P-value to exit of >0.2, except for LTL,
age and sex which were forced in (model 4). We modeled age as a
linear term, and repeated the analyses adding a quadratic term, as
well as by grouping age in 5-year and 10-year categories intro-
duced as dummy variables.
This sample size provided 78% power (at alpha 0.05) to detect an
odds ratio of 2.5 when comparing LTL tertiles 1 vs. 3 in predicting
the upper third vs. the lower two thirds of CAC, and substantiallygreater power in a trend test for a graded response when the 3 LTL
tertiles are considered.
3. Results
3.1. Characteristics of the study sample (Table 1)
Men and women were on average 59 and 65 years of age,
respectively, at the CT examination. Only 16% of women completed
high school vs. 41% of men. BMI <25 kg/m2 was unusual (22% of
men and 6% of women), whereas BMI  30.0 kg/m2 (obesity) was
highly prevalent (36% and 66% of men and women, respectively) as
was BMI 25.0e29.9 kg/m2 (overweight) (43% and 28%, respec-
tively). One third of the men and half of the women had diabetes,
and 36% ofmen vs. only 6% of women smoked regularly. Mean HDL-
cholesterol concentrations were low in both sexes (1.02 in men and
1.23 mmol/l in women, comprising 21.4% and 24.5% of total
cholesterol, respectively); and 21% of the men and 42% of the
women reported being on lipid-lowering treatment.
3.2. Leukocyte telomere length
LTL declined consistently with age in both sexes (sex-adjusted
Spearman’s rho ¼ 0.282, P < 0.001). Women had longer age-
adjusted LTL than men (difference 0.171 kb, 95% CI 0.036e0.322).
None of the CHD risk factors were signiﬁcantly associated with LTL.
3.3. Coronary artery calciﬁcation
CAC was found in 65% of men and 52% of women; 30% of men
and 29% of women had CAC scores>100 (Table 1). Agewas strongly
associated with CAC (sex-adjusted Spearman’s rho ¼ 0.495,
P < 0.001; the prevalence of CAC scores >100 increased 9-fold in
men from age 45e49 to age 70 and older). At age 65 and older 92%
of men and 70% of women showed evidence of any CAC compared
with 69% of men and 36% of women aged 55e64 and 39% of men
aged 45e54. A CAC score of >100 was noted in 62% of men and 38%
of women aged 65 and older vs. 11% of men aged 45e54 and 21% of
women aged 55e64. After age adjustment, women were less likely
than men to have any calciﬁcation (OR ¼ 0.25, 95% CI 0.13e0.49),
CAC scores>100 (OR¼ 0.55, 95% CI 0.29e1.05), or CAC scores in the
upper tertile (OR¼ 0.52, 95% CI 0.28e0.99).We found no signiﬁcant
age-sex adjusted associations of education, smoking, exercise en-
ergy expenditure, BMI, diabetes, blood pressure, or LDL- and HDL-
cholesterol with CAC. There appeared to be an association with the
natural logarithm of triglycerides (CAC >100, OR ¼ 1.97, 95% CI
0.95e3.89) and with lipid-lowering therapy (CAC >100, OR ¼ 1.58,
95% CI 0.82e3.04).
3.4. Association of LTL with CAC scores
We ﬁrst determined the age-sex adjusted mean LTL by cate-
gories of CAC (Table 2). LTL declined with increasing CAC (P ¼ 0.026
for trend in median values of the three CAC groups).
We next assessed the association of LTL with CAC as the
dependent variable using logistic modeling (Table 3). Taking the
CAC 100 cutoff point as the outcome deﬁnition we found tertiles of
LTL to be associated with CAC (model 1, age- and sex-adjusted
OR ¼ 2.70, 95% CI 1.20e6.06 and OR ¼ 2.19, 95% CI 0.97e4.95 for
the low and mid vs. the upper LTL tertiles, respectively; P ¼ 0.011
for trend in LTL tertile medians). When we classiﬁed CAC as the
upper third vs. the lower two thirds (CAC cut-off point 78) the odds
in the low and mid tertiles of LTL were elevated in a similarly
graded manner compared with the upper tertile of LTL (model 1,
OR ¼ 2.55, 95% CI 1.19e5.48 and OR ¼ 1.74, 95% CI 0.80e3.76,
Table 1
Characteristics of the study sample of Palestinian residents of East Jerusalem
(mean  SD or %).
Men (n ¼ 171) Women (n ¼ 79)
Risk factors
Age at CT 59.1 (9.5) 64.8 (6.2)
Age range 45e77 55e76
Completed high school (%) 41.4 16.5
<8 yrs schooling (%) 37.4 65.8
BMI 28.3 (5.2) 31.5 (3.9)
Smoking (current, %) 36.3 6.3
Leisure-time physical activity
(MET-min/wk) (median, IQR)
158 (0e1050) 0 (0e228)
Diabetes (%) 35.1 50.6
Plasma cholesterol (mmol/l) 4.76 (0.88) 5.02 (1.09)
LDL-C (mmol/l) 3.06 (0.79) 2.96 (0.91)
HDL-C (mmol/l) 1.02 (0.26) 1.23 (0.31)
Triglycerides (mmol/l)
(median, IQR)
1.31 (1.02e1.85) 1.52 (1.12e2.43)
High lipid treatment (%) 21.1 41.8
Fasting glucose (mmol/l)
(median, IQR)
5.88 (5.49e7.10) 6.49 (5.72e8.99)
SBP 126.2 (19.5) 130.1 (19.5)
DBP 79.8 (10.0) 77.7 (11.0)
Leukocyte telomere length (kbp) 6.550 (0.534) 6.625 (0.545)
Coronary artery calciﬁcation
Any CAC (%, 95% CI) 64.9 (57.7e72.1) 51.9 (40.6e63.2)
Agatston score 100 (%, 95% CI) 30.4 (23.4e37.4) 29.1(18.9e39.4)
Percentiles
10 0 0
20 0 0
30 0 0
40 4 0
50 19 5
60 41 30
70 122 95
80 216 192
90 368 440
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undiminished after coronary risk factor adjustment (models 2 and
3) andmodel reduction [model 4, OR¼ 2.92 (95% CI 1.28e6.68) and
2.29 (0.99e5.30), respectively, Ptrend ¼ 0.008 for CAC >100;
OR ¼ 2.64 (95% CI 1.22e5.70) and 1.70 (0.78e3.69), respectively,
Ptrend ¼ 0.006 for CAC in the upper tertile]. An analysis of any CAC
vs. none is likely to be compromised since almost all men aged 65
and older in our sample showed CAC (92%). Nevertheless, we
applied this deﬁnition to permit comparison with published ﬁnd-
ings [11]. The association was weaker (multivariable-adjusted OR
for the lower vs. upper LTL tertile¼ 1.60, 95% CI 0.793.25, P¼ 0.15
for trend in LTL tertiles).3.5. Sensitivity analyses (data not shown)
Due to the strong association of age with CAC we repeated the
analyses modeling age as a continuous variable with linear and
quadratic terms, and by grouping age into 5-year and 10-yearTable 2
Association of CACa with LTL (dependent) adjusted for age and sex.
Independent variables B 95% CI P
No calciﬁcation 0 (referent) 0.072 (2df)
0.026 (trend)b
CAC < median 0.059 0.219 to 0.101 0.470
CAC > median 0.201 0.377 to 0.026 0.025
Sex [1 ¼ M, 0 ¼ F] 0.146 0.293 to 0.001 0.052
Age [yrs] 0.014 0.023 to 0.006 0.001
a CAC scores showing calciﬁcation were divided at the median. Adjusted
R2 ¼ 0.104.
b CAC introduced as a linear term using median CAC values for each group.categories introduced as dummy variables. The ﬁndings were not
materially affected. In additional analyses, we stratiﬁed by sex, and
excluded patients with diabetes and those on lipid-lowering
medications. Again, the ﬁndings were essentially unaltered. The
ﬁndings persisted similarly when we accounted for pack-years of
cigarettes smoked (which accounts for the cumulative effects of
smoking exposure) and were enhanced when total energy expen-
diture was substituted for leisure-time activity. The age-sex-
adjusted association was weaker when LTL was introduced as a
continuous variable: P ¼ 0.025 for CAC >100, P ¼ 0.069 for CAC in
the upper tertile, and P¼ 0.079 for any CAC, indicating that in these
data the association is not monotonic across the full LTL distribu-
tion, unlike with the tertile categorization.
4. Discussion
In this cross-sectional study of an urban Arab population with a
characteristically high prevalence of diabetes and at high risk of
CHD [16], we found an inverse age- and sex-adjusted association of
tertiled LTL with CAC scores of 100 and above and with scores in the
upper tertile. Multivariable adjustment for coronary risk factors did
not attenuate the association. The ﬁndings persisted in subjects
without diabetes and not on lipid-lowering medications.
We are aware of two previously published studies on the asso-
ciation of LTL with CAC. The report by Mainous et al., in which
volunteers were recruited by advertisements [11], showed a graded
association of similar magnitude to ours, albeit at lower cut-off
values of CAC than we used in our older subjects. In light of their
mode of sampling, the authors called for population-based conﬁr-
matory studies such as ours [11]. The main thrust of the second
study [12] was to assess the association of white blood cell telo-
merase activity (that was not measured in our study) with CAC in a
sample of 440 men. The authors reported a positive cross-sectional
association, but no signiﬁcant association with the incidence of
newly detected CAC in a longitudinal evaluation. In a subsample
comprising 129 individuals in whom LTL was also measured, the
authors reported signiﬁcant effect modiﬁcation whereby shorter
LTL in the presence of low telomerase activity predicted substan-
tially less CAC progression in contrast with the combination of
short LTL and high telomerase activity. Long LTL was not associated
with less CAC, irrespective of telomerase activity. In light of the
exploratory nature and small sample size of that study, its ﬁndings
require conﬁrmation and should be viewed with caution. Our
ﬁndings conﬁrm the Mainous study in a very different population,
thus providing support to this initial ﬁnding, and suggest broad
generalizability to diverse populations.
CAC, our outcome measure, reﬂects the burden of coronary
atherosclerosis [10] and is a far better independent predictor of
CHD than carotid IMT in asymptomatic adults [9]. Furthermore,
CAC is strongly predictive of CHD in various ethnic/racial groups
(non-Hispanic whites, non-Hispanic blacks, Hispanics and Chinese)
in the USA [8]. In our study we extended CAC measurements to a
middle-aged and elderly population sample drawn from urban-
dwelling East Jerusalem Arabs, an Eastern Mediterranean popula-
tion at high risk of CHD [16]. Projections based solely on de-
mographic shifts suggest that this regionwill experience the largest
increase in ischemic and cardiovascular mortality in the world by
the year 2020 [25].
We found only plasma triglycerides and use of statins to be
associated with CAC scores. Among the traditional coronary risk
factors, blood pressure may be the only one that shows a consistent
relation to CAC progression [26]. We were unable to demonstrate
an association with blood pressure in our sample of urban Pales-
tinians after age adjustment (but did detect independent associa-
tions of systolic blood pressure and of diabetes with CAC in a
Table 3
Association of LTL (in sex-speciﬁc tertiles) with CAC score using logistic regression.
Agatston >100 CAC upper tertile (Agatston > 78) Any CAC
OR 95% CI P trend** OR 95% CI P trend** OR 95% CI P trend**
Model 1eage-sex adjusted, n ¼ 250
LTL tertiles 1 2.70 1.20e6.06 0.011 2.55 1.19e5.48 0.008 1.60 0.79e3.25 0.15
2 2.19 0.97e4.95 1.74 0.80e3.76 1.58 0.79e3.17
3 1.00 (P ¼ 0.051)* 1.00 (P ¼ 0.055)* 1.00 (P ¼ 0.33)*
Sex 0.56 0.29e1.09 0.53 0.28e1.01 0.24 0.12e0.48
Age 1.12 1.08e1.17 1.12 1.07e1.16 1.13 1.09e1.17
Nagelkerke R2 0.269 0.261 0.283
Model 2eadjusted also for education and lifestyle variables, n ¼ 250a
LTL tertiles 1 2.79 1.23e6.37 0.011 2.63 1.21e5.69 0.008 1.57 0.77e3.21 0.18
2 2.31 1.00e5.31 1.82 0.82e4.00 1.58 0.78e3.22
3 1.00 (P ¼ 0.044)* 1.00 (P ¼ 0.051)* 1.00 (P ¼ 0.35)*
Model 3eadditional adjustment for CHD risk factors, n ¼ 249b
LTL tertiles 1 2.92 1.26e6.80 0.009 2.70 1.23e5.97 0.007 1.64 0.78e3.43 0.13
2 2.29 0.96e5.48 1.79 0.79e4.05 1.63 0.79e3.37
3 1.00 (P ¼ 0.041)* 1.00 (P ¼ 0.048)* 1.00 (P ¼ 0.30)*
Model 4ereduced model by backward stepwise elimination, n ¼ 249c
LTL tertiles 1 2.92 1.28e6.68 0.008 2.64 1.22e5.70 0.006 1.60 0.79e3.25 0.15
2 2.29 0.99e5.30 1.70 0.78e3.69 1.58 0.79e3.17
3 1.00 (P ¼ 0.037)* 1.00 (P ¼ 0.046)* 1.00 (P ¼ 0.33)*.
All models showed appropriate goodness of ﬁt by Hosmer and Lemeshow’s test.
*P-values in parentheses are for the test with the LT tertiles introduced as dummy variables on 2 df.
**Test for trend using median LTL tertile values.
a Adjusted, in addition to age and sex, also for education (<8 yrs, 8 yrs), leisure-time exercise (ln METs), BMI, smoking (current regular, past regular, never regular).
b Adjusted, in addition to the above, also for SBP, diabetes, computed LDL-cholesterol, HDL-cholesterol, ln triglycerides, statin use. 1 individual excluded due to missing lipid
values.
c Adjusted for risk factor covariates after eliminating those with P > 0.20 to exit in a backward stepwise procedure that commenced with the full model 3 (covariates
retained in the model: for CAC>100eage, sex, smoking and ln TG; for CAC upper tertileeage, sex, ln TG; for any CACeage, sex).
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adjusted analysis, OR ¼ 1.023 per mmHg, 95% CI 1.006e1.041,
P¼ 0.008 and OR¼ 3.69, 95% CI 1.072e12.7, P¼ 0.038, respectively,
unpublished). We can but speculate as to the reason. Some, but not
all studies, show the metabolic syndrome and diabetes to be
associated with greater prevalence, incidence and progression of
CAC (e.g. [27]). We found no cross-sectional association of CAC with
diabetes (in contrast with our ﬁndings in the parallel Jewish sample
[see above]) or with components of the metabolic syndrome (other
than plasma triglycerides). A potential explanation is that our
population-representative sample was overwhelmingly over-
weight and had a high prevalence of diabetes with only 19% of
individuals exhibiting normal glucose metabolism (fasting glucose
<5.6 mmol/l and post challenge glucose <7.8 mmol/l). Thus the
power of our sample may have been insufﬁcient to detect this as-
sociation if one indeed exists in the population.
Other than age and sex, none of the cardiovascular risk factors
were associated with LTL. A similar lack of association with the
traditional risk factors was largely evident among young Israeli
adults using the same mode of LTL measurement [28], whereas
others have shown inconsistent associations. It has been proposed
that social support and an ostensibly healthy dietary pattern
favorably modify the association of shorter LTL with CAC [29]. We
considered the sample size of our study to be insufﬁcient to assess
such possible effect modiﬁcation.
Monogenetic diseases that result in extremely short telomeres
and aplastic anemias are relatively rare [30]. However, in the gen-
eral population, LTL is considered to be a complex genetic trait,
given that its variation across individuals arises from an admixture
of factors, including genetic, epigenetic, i.e., paternal age at
conception, and to a lesser extent environmental (e.g. infection/
inﬂammation) that might impact on LTL at birth, its rapid attrition
during childhood and relatively slower attrition during adulthood
[31,32]. Recent genome-wide-association studies have identiﬁed a
number of genes associated with LTL in the general population,
including OBFC1, TERC, TERT, NAF1, and RTEL1, all of which areengaged in telomere maintenance [33e35]. The deciphering of
these associations points to their potential role in cardiovascular
disease [36,37] and in longevity [38]. It remains to be clariﬁed why
short mean LTL is associated with increased atherosclerosis. How-
ever, the ﬁnding that genes associated with LTL are also associated
with increased risk of CHD and CHD mortality [36e38] bolsters the
argument for causal inference in that shorter LTL (or the propensity
to shorter LTL) would precede atherosclerosis and CHD. On the
other hand, De Meyer et al., found no association of a family history
of cardiovascular disease (CVD) with LTL, and argue against a causal
role for shorter inherited LTL in CVD [39].
Several small sample studies have examined associations of
telomere length (TL) with CHD in a variety of cells and lineages in
the hematopoietic hierarchy. For instance, Spyridopoulos et al. [40]
reported strong correlations in TL between different leukocyte
lineages, including CD34 þ progenitor cells and, in general, a
shorter TL in these cells in patients with CHD vs. controls. Based on
these ﬁndings and given that LTL reﬂects TL in cells up and across
the hematopoietic hierarchy, it is reasonable to use LTL as an index
of TL dynamics in the hematopoietic system [41]. Despite some
variation between leukocyte subsets and across other tissues, their
TL measurement provides little information over and above that of
LTL in light of the ‘synchrony’ of TL in the different leukocyte lin-
eages and across tissues. Thus, individuals endowed with long or
short telomeres in one somatic cell type would have correspond-
ingly long or short telomeres in all other cell types regardless of age
[41e43].
A limitation of our study is the modest sample size, although the
ﬁndings generally withstood a number of sensitivity analyses,
including exclusion of the diabetes patients. A second limitation
lies in our use of a cross-sectional design, one that does not permit
resolution of directionality in cause-effect relationships. The fact
that we excluded clinical manifestations of CHD reduces the like-
lihood that CHD preceded and affected LTL rather than the other
way round. However, both LTL attrition and atherosclerosis could
be affected by the same determinants such as oxidation and
J.D. Kark et al. / Atherosclerosis 229 (2013) 363e368368inﬂammation [13]. As longitudinal designs are required to unravel
the antecedent-consequent relationships, analysis of systemic in-
ﬂammatory markers in cross-sectional mode is unlikely to be
informative in this regard.
In conclusion, this study reafﬁrms the inverse association be-
tween LTL and asymptomatic CAC, an established measure of the
burden of coronary atherosclerosis. Based on the LTL-CAC relation
and studies showing that a short LTL is associated with the clinical
manifestation of atherosclerosis, and given that LTL is highly heri-
table [44] and is primarily fashioned during the ﬁrst two decades of
the human life course [32,42], LTL in early life may play a dominant
role in the LTL-atherosclerosis connection. However, the speciﬁc
mechanisms that link LTL with atherosclerosis remain to be
elucidated.
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